Enantioselective Synthesis of Cyanohydrins by a Novel Aluminum Catalyst

Abstract

The development of a new chiral aluminum catalyst is reported. This catalyst has been applied efficiently to the asym­metric cyanosilylation of aldehydes.

aldehyde - cyanohydrin - trimethylsilylcyanide - asymmetric addition - aluminum

References

1a Trost BM. Yeh VSC. Angew. Chem. Int. Ed.  2002,  41:  861 

1b Trost BM. Terrell LR. J. Am. Chem. Soc.  2003,  125:  338 

1c Trost BM. Mino T. J. Am. Chem. Soc.  2003,  125:  2410 

1d Trost BM. Fettes A. Shireman BT. J. Am. Chem. Soc.  2004,  126:  2660 

Atom economy in organic synthesis:

2a Trost BM. Science  1991,  254:  1471 

2b Trost BM. Angew. Chem., Int. Ed. Engl.  1995,  34:  259 

3a Gaucher A. Ollivier J. Salaün J. Synlett  1991,  151 

3b Schwindt MA. Belmont DT. Carlson M. Franklin LC. Hendrickson VS. Karrick GL. Poc RW. Sobicray DM. Van de Vusse J. J. Org. Chem.  1996,  61:  9564 

3c Effenberger F. Jäger JJ. J. Org. Chem.  1997,  62:  3867 

For reviews on enantioselective synthesis and applications of cyanohydrins:

4a Effenberger F. Angew. Chem., Int. Ed. Engl.  1994,  33:  1555 

4b Gregory RJH. Chem. Rev.  1999,  99:  3649 

4c North M. Tetrahedron: Asymmetry  2003,  14:  147 

4d Brunel J.-M. Holmes IP. Angew. Chem. Int. Ed.  2004,  43:  2752 

For aluminum-catalyzed TMSCN enantioselective addition to aldehydes see:

5a Iovel I. Popelis Y. Fleisher M. Lukevics E. Tetrahedron: Asymmetry  1997,  8:  1279 

5b Hamashima Y. Sawada D. Nogami H. Kanai M. Shibasaki M. Tetrahedron  2001,  57:  805 

5c Casas J. Nájera C. Sansano JM. Saá JM. Org. Lett.  2002,  4:  2589 

5d For aluminum-catalyzed TMSCN enantioselective addition to ketones see: Deng H. Isler MP. Snapper ML. Hoveyda AH. Angew. Chem. Int. Ed.  2002,  41:  1009 

6

Temperature of a cold room.

7

Typical Procedure
Catalysis Generation: A 2 M solution of trimethylalu-minum in toluene (25 µL, 0.05 mmol) was added dropwise to a solution of ligand 1 (36 mg, 0.056 mmol) in 1.0 mL of chlorobenzene at r.t. After stirring for 30 min at the same temperature, the resulting solution was cooled to 4 °C to be used as catalyst. TMSCN Addition: Aldehyde 2 (0.5 mmol) was added in one portion to the catalyst solution at 4 °C and after 10 min TMSCN (73 µL, 0.55 mmol) was added over 2 min. The reaction mixture was stirred at the same temperature for 24 h. Then the reaction was quenched with 2.0 mL of pH 7 buffer phosphate solution (Na₂HPO₄/NaH₂PO₄) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine (5 mL), dried over MgSO₄ and concentrated to give a colorless oil. The crude was purified by flash chromatography on silica gel (petroleum ether-EtOAc, 5:1) to yield the corresponding silylated cyanohydrins.

8a Brusse J. Roos EC. Van der Gen A. Tetrahedron Lett.  1988,  29:  4485 

8b Almsick A. Buddrus J. Hoenicke-Schmidt P. Laumen K. Schneider M. J. Chem. Soc., Chem. Commun.  1989,  18:  1391 

8c Effenberger F. Hörsch B. Förster S. Ziegler T. Tetrahedron Lett.  1990,  31:  1249 

8d Effenberg R. Gutterer B. Ziegler T. Liebigs Ann. Chem.  1991,  269 

8e Dhanoa D. Bagley SW. Chang RSL. Lotti VJ. Chen T.-B. J. Med. Chem.  1993,  36:  3738 

8f Effenberger F. Eichhorn J. Tetrahedron: Asymmetry  1997,  8:  469 

8g Hwang CD. Hwang D.-R. Uang B.-J. J. Org. Chem.  1998,  63:  6762 

8h Yang WB. Fang JM. J. Org. Chem.  1998,  63:  1356 

8i Abiko A. Wang G. Tetrahedron  1998,  54:  11405 

8j Liang S. Bu XR. J. Org. Chem.  2002,  67:  2702 

8k Nogami H. Motomu K. Shibasaki M. Chem. Pharm. Bull.  2003,  51:  702 

9

Characterization of the New Compounds:
Compound 3c: ¹H NMR (300 MHz, CDCl₃): δ = 7.32 (s, 2 H), 7.26 (s, 1 H), 5.66 (s, 1 H), 2.59 (s, 3 H), 0.48 (s, 9 H) ppm. ¹³C NMR (300 MHz, CDCl₃): δ = 138.8, 136.2, 131.0, 124.2, 119.5, 63.8, 21.3, -0.1 ppm. IR (neat): 2960, 2921, 1612, 1464, 1255, 1159, 1101, 846, 754, 692 cm^-1. Anal. Calcd for C₁₃H₁₉NOSi: C, 66.90; H, 8.21; N, 6.00. Found: C, 66.67; H, 7.95; N, 5.95. Enantiomer separation by HPLC (Daicel Chiralpak AD, λ = 250 nm, heptane-i-PrOH = 99.95:0.05; 1.0 mL/min; 57% ee): t _R = 6.83 (major) and 7.98 min. [α]_D -16.28 (c 2.12, CHCl₃).
Compound 3f: ¹H NMR (300 MHz, CDCl₃): δ = 7.36 (m, 3 H), 5.43 (s, 1 H), 0.27 (s, 9 H) ppm. ¹³C NMR (300 MHz, CDCl₃): δ = 139.5, 135.7, 129.6, 124.8, 118.3, 62.4, -0.2 ppm. IR (neat): 3083, 2961, 2901, 1592, 1574, 1435, 1259, 1202, 1119, 872, 805, 754 cm^-1. Anal. Calcd for C₁₁H₁₃Cl₂NOSi: C, 48.18; H, 4.78; N, 5.11. Found: C, 48.61; H, 5.17; N, 5.03. Enantiomer separation by HPLC (Daicel Chiralpak AD, λ = 235 nm, heptane-i-PrOH = 99.5:0.5; 0.6 mL/min; 80% ee): t _R = 9.80 and 10.48 (major) min.
[α]_D -12.52 (c 2.91, CHCl₃).
Compound 3g: ¹H NMR (300 MHz, CDCl₃): δ = 7.69 (m, 1 H), 7.55 (m, 2 H), 5.43 (s, 1 H), 0.27 (s, 9 H) ppm. ¹³C NMR (300 MHz, CDCl₃): δ = 139.9, 135.1, 128.1, 123.5, 118.2, 62.2, -0.2 ppm. IR (neat): 3076, 2959, 1589, 1562, 1427, 1256, 1193, 1118, 1095, 848, 742 cm^-1. Anal. Calcd for C₁₁H₁₃Br₂NOSi: C, 36.38; H, 3.61; N, 3.86. Found: C, 36.01; H, 2.99; N, 3.94. Enantiomer separation by HPLC (Daicel Chiralcel OD, λ = 235 nm, heptane-i-PrOH = 99.8:0.2, 1.0 mL/min; 85% ee): t _R = 11.69 (major) and 16.01 min.
[α]_D -9.39 (c 2.53, CHCl₃).
Compound 3h: ¹H NMR (300 MHz, CDCl₃): δ = 7.49 (s, 1 H), 7.39-7.32 (m, 3 H), 5.45 (s, 1 H), 2.44 (t, J = 6.9 Hz, 2 H), 1.60-1.47 (m, 4 H), 0.98 (t, J = 6.9 Hz, 3 H) ppm. ¹³C NMR (300 MHz, CDCl₃): δ = 136.4, 132.5, 129.5, 128.9, 125.4, 125.0, 119.0, 91.6, 79.9, 63.4, 30.8, 22.1, 19.1, 13.7, -0.2 ppm. IR (neat): 2959, 2934, 2873, 2230, 1603, 1482, 1431, 1330, 1256, 1108, 1082, 860, 848 cm^-1. Anal. Calcd for C₁₇H₂₃NOSi: C, 71.53; H, 8.12; N, 4.91. Found: C, 70.98; H, 8.51; N, 5.05. Enantiomer separation by HPLC (Daicel Chiralcel OD, λ = 250 nm, heptane-i-PrOH = 99.7:0.3; 1.0 mL/min; 82% ee): t _R = 18.16 (major) and 30.05 min. [α]_D -9.11 (c 0.26, CHCl₃).